The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.


Updates from The Motley Fool

Latest updates on Allergan from Fool.com.  The Fool has written over 200 articles on Allergan.
4 Stocks We Would Never Sell

It can be difficult to hold on to stocks for decades at a time, because investors can't predict t...

3 Stocks Billionaires Are Buying

Billionaire investors Warren Buffett, George Soros, and Carl Icahn recently made these big bets.



Stock Performance

View Interactive AGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Allergan.
Current Price: $243.86
Prev Close: $243.05
Open: $243.09
Bid: $239.00
Ask: $243.83
Day's Range: $240.56 - $244.15
52wk Range: $184.50 - $261.27
Volume: 1,832,043
Avg Vol 2,247,673
Market Cap: $82B
P/E (ttm): -76.67
EPS (ttm): ($3.17)
Div & Yield: $2.80 (1.2%)

Company Rating

What our community thinks about Allergan.
CAPS Rating 4 out of 5
 
425 Outperform
29 Underperform
CAPS All Stars
 
103 Outperform
7 Underperform

How do you think Allergan will perform against the market?



You pick for Allergan is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Brenton L. Saunders, CEO

76% Approve

Based on 107 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Allergan.

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers